Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Curr HIV Res. 2016;14(5):431–441. doi: 10.2174/1570162x14666160324125536

Figure 1.

Figure 1

Shock and kill approach aiming to reactivate latently infected cells by HDAC inhibition including suberoylanilide hydroxamic acid (SAHA), the BET bromodomain protein inhibitor (BET151), and anti-CTLA4 antibody and induce subsequent cell death due to viral toxicity and/or host immune defense while HIV-1 replication is inhibited by ART.